These findings result in tumour to kidney and tumour to liver ratios of 0.014 ± 0.004 and 1.1 ± 0.4, respectively, demonstrating that the nanobody 99mTc-D10 was excreted via the kidney. The gene discussed is CHRFAM7A; the disease is neoplasm.